Lucid Diagnostics, Inc. (LUCD)
1.03
-0.02
(-1.90%)
USD |
NASDAQ |
May 29, 16:00
1.035
0.00 (0.00%)
After-Hours: 20:00
Lucid Diagnostics EPS Diluted (Quarterly) : -0.1686 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| PAVmed, Inc. | -4.421 |
| ClearPoint Neuro, Inc. | -0.3233 |
| Penumbra, Inc. | 0.824 |
| Hyperfine, Inc. | -0.0883 |
| Abbott Laboratories | 0.6165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.91M |
| Revenue (Quarterly) | 1.256M |
| Total Expenses (Quarterly) | 15.16M |
| Enterprise Value | 205.54M |
| Gross Profit Margin (Quarterly) | -47.05% |
| Profit Margin (Quarterly) | -1.11K% |
| Earnings Yield | -45.49% |
| Normalized Earnings Yield | -48.85 |